Teva Pharmaceutical Industries (TEVA) earnings

Earnings (net income) · fiscal 2025
$1.41B

Teva Pharmaceutical Industries (TEVA) reported net income of $1.41B in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$1.64B. Figures as of 18 Nov 2026, 09:47 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
$1.41B
Growth, 10 years
−1.2% a year
Highest on record
$3.33Bfiscal 2010
Lowest on record
-$16.27Bfiscal 2017
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Teva Pharmaceutical Industries earnings, in more detail

Over the ten fiscal years to 2025 net income shrank at a compound 1.2% a year. Across the 19 fiscal years on record (2007–2025), the highest was $3.33B in fiscal 2010 and the lowest -$16.27B in fiscal 2017.

History · 19 fiscal years

Earnings (net income) by fiscal year

Teva Pharmaceutical Industries earnings, year by year

Teva Pharmaceutical Industries (TEVA) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025$1.41B—
2024-$1.64B—
2023-$559.00M—
2022-$2.45B 686.6% down
2021$417.00M—
2020-$3.99B—
2019-$999.00M—
2018-$2.15B—
2017-$16.27B 5,043.8% down
2016$329.00M 79.3% down
2015$1.59B 48.0% down
2014$3.06B 140.7% up
2013$1.27B 35.4% down
2012$1.96B 28.9% down
2011$2.76B 17.2% down
2010$3.33B 66.6% up
2009$2.00B 228.4% up
2008$609.00M 68.2% down
2007$1.91B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Teva Pharmaceutical Industries and comparable companies
CompanyEarnings (net income)Fiscal year
Medline MDLN$1.16B2025
Humana HUM$1.19B2025
Teva Pharmaceutical Industries TEVA$1.41B2025
Waters WAT$642.63M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TEVA

Teva Pharmaceutical Industries, figure by figure

Teva Pharmaceutical Industries (TEVA) overview: price, valuation and scorecardAll health care companies by market value

Teva Pharmaceutical Industries earnings: questions and answers

What is Teva Pharmaceutical Industries's net income?

Teva Pharmaceutical Industries (TEVA) reported net income of $1.41B in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$1.64B.

What is the growth rate of Teva Pharmaceutical Industries's net income?

Over the ten fiscal years to 2025 net income shrank at a compound 1.2% a year.

What are the highest and lowest net income figures on record for Teva Pharmaceutical Industries?

Across the 19 fiscal years on record (2007–2025), the highest was $3.33B in fiscal 2010 and the lowest -$16.27B in fiscal 2017.

How is Teva Pharmaceutical Industries's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement. For Teva Pharmaceutical Industries it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Teva Pharmaceutical Industries (TEVA) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/TEVA/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.